William Lewis - 04 Jan 2024 Form 3 Insider Report for NewAmsterdam Pharma Co N.V. (NAMS)

Role
Director
Signature
/s/ William Lewis
Issuer symbol
NAMS
Transactions as of
04 Jan 2024
Net transactions value
$0
Form type
3
Filing time
08 Jan 2024, 19:40:31 UTC
Previous filing
31 Oct 2023
Next filing
10 Jan 2024

No securities are beneficially owned.